Advanced search
Publication Cover
Infection and Drug Resistance Volume 13, 2020 - Issue
Submit an article Journal homepage
121
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Serum Concentration of Vancomycin Is a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Septic Patients in Clinical and Surgical Wards

Welder Zamoner1 Botucatu School of Medicine, São Paulo State University - UNESP, Botucatu, São Paulo, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2756-6621
ORCID Icon,
Isabella Gonçalves Pierri1 Botucatu School of Medicine, São Paulo State University - UNESP, Botucatu, São Paulo, Brazil
,
Karina Zanchetta Cardoso Eid1 Botucatu School of Medicine, São Paulo State University - UNESP, Botucatu, São Paulo, Brazil
,
Lais Maria Bellaver de Almeida1 Botucatu School of Medicine, São Paulo State University - UNESP, Botucatu, São Paulo, Brazil
,
Adriano dos Santos2 Clinics Hospital Pharmacy, Botucatu School of Medicine, Botucatu, São Paulo18618-970, Brazil
,
André Luís Balbi1 Botucatu School of Medicine, São Paulo State University - UNESP, Botucatu, São Paulo, Brazil
&
Daniela Ponce1 Botucatu School of Medicine, São Paulo State University - UNESP, Botucatu, São Paulo, Brazil
 show all
Pages 403-411 | Published online: 10 Feb 2020

References

  • Lentini P, De Cal M, Clementi A, D’Angelo A, Ronco C. Sepsis and AKI in ICU patients: the role of plasma biomarkers. Crit Care Res Pract. 2012;2012:1–5. doi:10.1155/2012/856401
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.02826903338
  • Schier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351(2):159–169. doi:10.1056/NEJMra03240115247356
  • Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol. 2011;22(6):999–1006. doi:10.1681/ASN.201005048421566052
  • Kidney Disease: improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138. doi:10.1038/kisup.2012.1
  • Eyler RF, Mueller BA. Antibiotic dosing in critically ill patients with acute kidney injury. Nat Rev Nephrol. 2011;7(4):226–235. doi:10.1038/nrneph.2011.1221343897
  • Lewis SJ, Mueller BA. Antibiotic dosing in patients with acute kidney injury: “Enough but not too much”. J Intensive Care Med. 2016;31(3):164–176. doi:10.1177/088506661455549025326429
  • Zamoner W, Freitas FM, Garms DSS, Oliveira MG, Balbi AL, Ponce D. Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients. Pharmacol Res Perspect. 2016;4(6):e00280. doi:10.1002/prp2.28028097012
  • Hiramatsu K. Vancomycin resistance in Staphylococci. Drug Resist Updat. 1998;1(2):135–150. PMID:16904400. doi:10.1016/S1368-7646(98)80029-016904400
  • Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29(11):1275–1279. PMID:19873687. doi:10.1592/phco.29.11.127519873687
  • Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm. 2009;66:82–98. doi:10.2146/ajhp08043419106348
  • Iwamoto T, Kagawa Y, Kojima M. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol Pharm Bull. 2003;26(6):876–879. PMID:12808304 876-9. doi:10.1248/bpb.26.87612808304
  • Davis SL, Scheetz MH, Bosso JÁ, Goff DA, Rybak MJ. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals. Pharmacotherapy. 2013;33(12):1256–1263. doi:10.1002/phar.132723897602
  • Ponce D, Zorzenon CDPF, Santos NY, Teixeira UA, Balbi AL. Acute kidney injury in intensive care unit patients: a prospective study on incidence, risk factors and mortality. Rev Bras Ter Intensiva. 2011;23(3):321–326. PMID:23949404. doi:10.1590/S0103-507X201100030001023949404
  • Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol. 2012;68(9):1243–1255. doi:10.1007/s00228-012-1259-922411630
  • Gupta A, Biyani M, Khaira A. Vancomycin nephrotoxicity; myths and facts. Neth J Med. 2011;69(9):379–383. PMID:21978980.21978980
  • Bosso JA, Nappi J, Rudisill C, et al. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011;55(12):5475–5479. doi:10.1128/AAC.00168-1121947388

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.